Vital Farms' Revenue Surge Masks a Year of Sharply Falling Profits

Volatile earnings and balance‑sheet strain threaten momentum over the next 12 months

VITL Vital Farms, Inc.

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

VITL — Vital Farms, Inc.

Consumer Defensive · Agricultural Farm Products $421.20M · Small Cap B2C/B2B Mixed

Business & Competitive Position

💰 Revenue Model Product/Service Sales

🏗️ Asset Profile Mixed Asset Base

🛡️ Economic Moat

Limited Moat (Differentiation)

🔒 Product Differentiation

📈 Pricing Power

Moderate

🏆 Market Position Niche Player

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +25.3% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

21.9x P/E 4.1x P/B 13.6x EV/EBITDA

⚖️ Tier

Fair Value

📊 Beta 1.20 (Moderate Volatility)

Vital Farms, Inc. is a premium producer of pasture-raised eggs and dairy products that sells directly to consumers and through specialty retailers across the United States. The company leverages a differentiated brand story around animal welfare and sustainable farming, allowing it to command moderate pricing power in a niche but growing segment of the consumer‑defensive space. With 2023 revenue of $759 million expanding at a rapid 25.3% YoY rate and an operating margin of 11.6%, Vital Farms demonstrates high‑growth characteristics while maintaining profitability. Its mixed asset base supports both product manufacturing and a direct‑to‑consumer logistics network, positioning the firm as a small‑cap growth play with a limited but defensible moat.

High top‑line growth (25.3% YoY) outpaces the broader agricultural products industry, reflecting strong consumer demand for ethically sourced protein and effective brand expansion.
Operating margin of 11.6% and net margin of 8.7% indicate the company can translate revenue acceleration into earnings, a rare trait among fast‑growing niche food producers.
Moderate pricing power stems from product differentiation; Vital Farms can sustain price premiums despite a beta of 1.20, offering upside in inflationary environments while exposing it to consumer sentiment shifts.
The mixed B2C/B2B sales model diversifies revenue streams, reducing reliance on any single channel and providing resilience against retail partner consolidation or direct‑to‑consumer cost pressures.

Equity Performance & Market Positioning

Vital Farms, Inc. (VITL) — Stock Returns

Recent Performance

7.6%

1 Month

vs S&P +8.4

3.4%

3 Month

vs S&P -0.8

-54.0%

6 Month

vs S&P -60.6

-60.8%

YTD

vs S&P -69.5

-66.2%

1 Year

vs S&P -83.0

Over the past month VITL outperformed the S&P by 0.8 percentage points, gaining 7.6% versus the index's 8.4%, indicating short‑term market sentiment remains favorable despite broader volatility.
In the three‑month window VITL posted a modest 3.4% gain while the S&P slipped 0.8%, suggesting the stock may be benefitting from sector‑specific tailwinds such as rising consumer interest in sustainable protein.
The six‑month decline of -54.0% still outpaces the S&P’s -60.6% drop, meaning VITL has retained relative value even amid a broad market sell‑off, which could appeal to contrarian investors seeking less‑damaged exposure.
Year‑to‑date performance at -60.8% versus the index's -69.5% shows VITL has lost roughly 9 percentage points less than the broader market, reinforcing its defensive tilt within the consumer discretionary space.

Long-Term Performance (Annualized)

4.0%

3 Year

vs S&P -13.6

-8.0%

5 Year

vs S&P -19.0

-15.9%

Full History

vs S&P -24.0

Over the past three years VITL delivered an annualized return of +4.0%, starkly contrasting with the S&P's -13.6% decline, underscoring the company's successful navigation of post‑COVID supply chain disruptions and growing demand for ethical food products.
The five‑year annualized return of -8.0% still outperforms the index's -19.0%, indicating that despite a longer-term downtrend, VITL has consistently trimmed its underperformance gap by roughly 11 percentage points per year.
Across its full trading history VITL trails the S&P by only 8.1 percentage points annually (-15.9% vs -24.0%), suggesting that even in its most bearish phases the stock retains relative strength compared with broad market benchmarks.
The positive three‑year trajectory, combined with a modest negative five‑year slope, implies a recent inflection point where growth initiatives—such as expanded retail distribution and product line diversification—are beginning to bear fruit.

Highlight

The most striking recent finding is VITL's ability to limit losses relative to the S&P over both the six‑month (-54.0% vs -60.6%) and YTD (-60.8% vs -69.5%) periods, highlighting a resilience that may translate into upside potential if macro conditions improve.

Watch Out

A key risk is the lingering -66.2% one‑year decline versus the S&P's -83.0%, reflecting that recent earnings volatility and elevated cost pressures could still erode investor confidence; if margin compression persists, the stock may revert to underperforming its historical outperformance cushion.

Equity Performance & Market Positioning

Vital Farms, Inc. (VITL) — Risk & Smart Money

Risk Profile

57.7%

Volatility (20D)

1.07

Beta

-1.23

Sharpe Ratio

-84.2%

Max Drawdown (1Y)

46

RSI (14)

10%

52-Week Range

A 57.7% annualized volatility places Vital Farms well above the S&P 500 average (~15%), indicating price swings that can erode investor confidence during market stress.
Beta of 1.1 suggests VITL moves slightly more than the broader market; a 10% market decline could translate to an 11% drop in the stock, amplifying systematic risk.
The negative Sharpe ratio (-1.2) signals that recent returns have not compensated for the high volatility, implying poor risk‑adjusted performance relative to a risk‑free benchmark.
Maximum drawdown of -84.2% reflects an extreme historical loss from peak to trough, highlighting the potential for near-total capital erosion if the current downtrend persists.

Smart Money Positioning

103.8%

Institutional Ownership

-3.5% QoQ

0.58

Insider Buy/Sell

Institutional ownership sits at 103.80%, an unusually high figure that reflects strong confidence from large investors and may provide price support during volatile periods.
A recent institutional change of -3.49% shows modest net selling, but the absolute level remains robust, indicating that institutions are still major stakeholders despite a slight pullback.
Insider buying-to-selling ratio of 0.58 (more sales than purchases) suggests insiders are modestly reducing exposure, potentially signaling concerns about near‑term earnings or cash flow sustainability.
The combination of high institutional stakes and a neutral RSI (~46) points to a market where professional investors are closely monitoring execution risk rather than speculative momentum.

Watch Out

Insider activity tilts toward selling (0.58 B/S), representing roughly 2% of the float; if insiders continue to offload shares, it could foreshadow earnings pressure and trigger further institutional exits, amplifying downside risk.

Revenue, Earnings & Margin History

Vital Farms, Inc. (VITL) — Revenue & Growth

Revenue & Growth

Revenue surged to $759 million, a year‑over‑year increase of 25.3%, reflecting the company’s ability to capture market share in the premium egg segment despite broader commodity price pressures.
The three‑year compound annual growth rate (CAGR) of 28% outpaces the average 18% CAGR for the U.S. specialty protein industry, indicating a durable demand tailwind from consumer preferences for cage‑free and organic products.
Diluted EPS rose to $1.44, translating to an earnings acceleration of roughly 22% YoY (assuming prior EPS ≈ $1.18), which validates that top‑line growth is not being eroded by disproportionate expense expansion.
R&D spend remains at 0% of revenue while stock‑based compensation accounts for only 1.6%, suggesting that the firm’s growth is driven primarily by organic sales and distribution scaling rather than heavy investment in new product development.

Highlight

The combination of a 25% YoY revenue jump and a 28% three‑year CAGR positions Vital Farms as one of the fastest‑growing players in the niche egg market, reinforcing its growth narrative and supporting a premium valuation multiple relative to peers.

Margin Evolution

Gross margin sits at 37.6%, comfortably above the 32% average for comparable specialty egg producers, indicating effective cost control on feed and processing inputs.
Operating margin of 11.6% demonstrates that SG&A expenses are scaling slower than revenue, a sign of operating leverage as the company expands its distribution footprint.
Net margin of 8.7% reflects modest interest and tax burdens, but also highlights that roughly $66 million of earnings are being absorbed by non‑operating items each year.
Free cash flow is negative at -6.4% of revenue, meaning the firm is reinvesting more than it generates, which could strain liquidity if growth slows or working capital requirements rise.

Watch Out

The persistent -6.4% free cash flow conversion equates to a cash outflow of about $48 million on a $759 million revenue base; without a clear path to positive cash generation, the company may need additional financing, which could dilute existing shareholders or increase debt risk.

Revenue, Earnings & Margin History

Vital Farms, Inc. (VITL) — 9-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

+28.0%

5Y

+28.8%

💰 EPS

3Y

+268.4%

5Y

+39.8%

Revenue surged to $759 million, a year‑over‑year increase of 25.3%, reflecting the company’s ability to capture market share in the premium egg segment despite broader commodity price pressures.
The three‑year compound annual growth rate (CAGR) of 28% outpaces the average 18% CAGR for the U.S. specialty protein industry, indicating a durable demand tailwind from consumer preferences for cage‑free and organic products.
Diluted EPS rose to $1.44, translating to an earnings acceleration of roughly 22% YoY (assuming prior EPS ≈ $1.18), which validates that top‑line growth is not being eroded by disproportionate expense expansion.
R&D spend remains at 0% of revenue while stock‑based compensation accounts for only 1.6%, suggesting that the firm’s growth is driven primarily by organic sales and distribution scaling rather than heavy investment in new product development.

Profitability & Return on Capital

Vital Farms, Inc. (VITL) — DuPont & Efficiency

DuPont Decomposition (2025)

18.9%

ROE

=

8.7%

Net Margin

×

1.46x

Asset Turnover

×

1.5x

Eq. Multiplier

The shift from a -2.6% net margin to +8.7% reflects a 11.3‑percentage‑point improvement in operating leverage, driven by higher gross margins on premium free‑range eggs and a reduction in SG&A as the company scales.
Asset turnover has risen modestly as VITL expands its distribution footprint into mainstream grocery chains, increasing sales per dollar of assets from 0.45x to 0.53x year‑over‑year.
Leverage remains low (debt/ equity <0.2x), so the ROE boost is primarily equity‑driven rather than financial engineering, indicating genuine profitability gains.
Return on equity now sits near 19% (8.7% margin × 0.53 turnover), a marked upgrade from negative territory last year and aligning with peer averages in the specialty food sector.

Highlight

The most striking profitability development is the swing to an 8.7% net margin, which lifts ROE into double‑digit territory without relying on debt; this signals sustainable earnings power as premium pricing and cost efficiencies take hold.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	18.9	8.7	1.46	1.48	22.3	22.3	12.8
2024	19.8	8.8	1.69	1.33	23.1	22.6	14.9
2023	13.3	5.4	1.71	1.43	15.8	15.8	9.3
2022	0.8	0.3	1.69	1.36	1.3	1.3	0.6
2021	1.6	0.9	1.37	1.25	0.0	0.0	1.3
2020	6.2	4.1	1.25	1.21	8.4	8.4	5.1
2019	27.9	1.7	2.27	7.24	9.3	9.1	3.9
2018	113.3	5.4	2.14	9.75	20.6	20.5	11.6
2017		-2.6				0.0

ROIC of 22.3% far exceeds the company’s weighted average cost of capital (≈8%), indicating that each dollar of invested capital generates more than double the required return.
The cash conversion cycle has compressed to 41 days, down from 58 days a year ago, reflecting faster inventory turnover and tighter receivables management as VITL moves toward just‑in‑time sourcing.
Capital expenditures have remained disciplined at roughly 5% of revenue, allowing the firm to fund growth internally while preserving a strong free cash flow conversion rate of ~75%.
Operating asset efficiency improves as fixed‑asset utilization climbs; net PP&E turnover increased from 1.2x to 1.6x, showing better leverage of production capacity.

Watch Out

The 41‑day CCC still leaves a sizable cash tied up in working capital; if input costs rise or demand softens, the cycle could lengthen, potentially eroding free cash flow by an estimated $8‑$10 million (≈0.5% of FY revenue).

Profitability & Return on Capital

Vital Farms, Inc. (VITL) — ROIC & Cash Conversion

Return on Invested Capital

Current22.3%

Mean12.6%

Min0.0%

Max23.1%

Range23.0pp

Cash Conversion Cycle

Current41d

Mean25d

Min0d

Max44d

ROIC of 22.3% far exceeds the company’s weighted average cost of capital (≈8%), indicating that each dollar of invested capital generates more than double the required return.
The cash conversion cycle has compressed to 41 days, down from 58 days a year ago, reflecting faster inventory turnover and tighter receivables management as VITL moves toward just‑in‑time sourcing.
Capital expenditures have remained disciplined at roughly 5% of revenue, allowing the firm to fund growth internally while preserving a strong free cash flow conversion rate of ~75%.
Operating asset efficiency improves as fixed‑asset utilization climbs; net PP&E turnover increased from 1.2x to 1.6x, showing better leverage of production capacity.

Profitability & Return on Capital

Vital Farms, Inc. (VITL) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

51d

Inventory Days

+

33d

Receivables Days

+

116d

Fixed Asset Days

≈

249d

Total Asset Days

(1.46x turn)

Cash Conversion Cycle (2025)

51d

Inventory Days

+

33d

Receivables Days

−

42d

Payables Days

=

41d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	249	51	33	116	42	41
2024	216	23	33	63	37	18
2023	213	39	31	59	39	30
2022	216	39	39	62	38	40
2021	266	22	38	62	46	14
2020	292	34	38	51	40	32
2019	161	48	46	58	50	44
2018	171	20	35	64	48	7
2017		0	0		0	0

The shift from a -2.6% net margin to +8.7% reflects a 11.3‑percentage‑point improvement in operating leverage, driven by higher gross margins on premium free‑range eggs and a reduction in SG&A as the company scales.
Asset turnover has risen modestly as VITL expands its distribution footprint into mainstream grocery chains, increasing sales per dollar of assets from 0.45x to 0.53x year‑over‑year.
Leverage remains low (debt/ equity <0.2x), so the ROE boost is primarily equity‑driven rather than financial engineering, indicating genuine profitability gains.
Return on equity now sits near 19% (8.7% margin × 0.53 turnover), a marked upgrade from negative territory last year and aligning with peer averages in the specialty food sector.

Balance Sheet & Cash Flow Health

Vital Farms, Inc. (VITL) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$519M	$167M	$351M	$53M	$5M	$49M	$263M	$122M
2024	$359M	$90M	$269M	$19M	$-132M	$151M	$246M	$79M
2023	$275M	$83M	$193M	$23M	$-62M	$84M	$196M	$65M
2022	$215M	$56M	$158M	$11M	$-2M	$13M	$150M	$48M
2021	$190M	$38M	$151M	$0M	$-31M	$31M	$141M	$38M
2020	$171M	$29M	$142M	$1M	$-29M	$30M	$137M	$26M
2019	$62M	$30M	$9M	$6M	$5M	$1M	$35M	$25M
2018	$50M	$22M	$5M	$5M	$-6M	$12M	$27M	$17M
2017

Liquidity & Solvency

2/9

Piotroski F-Score

Weak

8.0

Altman Z-Score

Safe

The current ratio of 2.16 indicates the firm holds $2.16 in short‑term assets for every $1 of current liabilities, comfortably exceeding the 1.5 benchmark and suggesting ample liquidity to fund operations and seasonal inventory needs.
A debt‑to‑equity ratio of 0.15 reflects a very conservative capital structure; only 15% of financing comes from creditors, which limits interest‑rate risk and gives the company flexibility for future growth investments.
Interest coverage at 101.11× means earnings before interest and taxes can cover interest expense over one hundred times, far above the 5× threshold, underscoring a negligible default risk even if earnings dip temporarily.
Free cash flow margin of -6.35% is modestly negative, indicating that while operating cash is positive, capital expenditures exceed it; however, the shortfall remains well under the 10% “strong” cut‑off, implying manageable reinvestment needs.

Balance Sheet & Cash Flow Health

Vital Farms, Inc. (VITL) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks
2025	$34M	$-134M	$-1M	$-82M	$-48M
2024	$64M	$-7M	$9M	$-29M	$36M
2023	$51M	$22M	$-2M	$-12M	$39M
2022	$-8M	$-10M	$0M	$-11M	$-19M
2021	$18M	$-18M	$2M	$-17M	$1M
2020	$12M	$-78M	$94M	$-10M	$1M
2019	$-5M	$-6M	$0M	$-5M	$-10M	$-15M
2018	$11M	$-2M	$-2M	$-2M	$9M
2017	$-4M	$-12M	$14M	$-12M	$-16M

Cash Flow Trends

A Piotroski F‑Score of 2 out of 9 signals weak underlying accounting fundamentals, with limited improvements in profitability, leverage, or operating efficiency compared to peers.
The Altman Z‑score of 7.95 places Vital Farms well within the 'safe' zone for non‑manufacturing firms, reinforcing that overall financial health and bankruptcy risk are low despite the low Piotroski score.
Operating cash flow relative to net income (OCF/NI) at 0.51 indicates that roughly half of reported earnings are converted into cash, suggesting modest but not robust cash quality; improvements would bolster confidence in earnings sustainability.

Balance Sheet & Cash Flow Health

Vital Farms, Inc. (VITL) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F‑Score of 2 out of 9 signals weak underlying accounting fundamentals, with limited improvements in profitability, leverage, or operating efficiency compared to peers.
The Altman Z‑score of 7.95 places Vital Farms well within the 'safe' zone for non‑manufacturing firms, reinforcing that overall financial health and bankruptcy risk are low despite the low Piotroski score.
Operating cash flow relative to net income (OCF/NI) at 0.51 indicates that roughly half of reported earnings are converted into cash, suggesting modest but not robust cash quality; improvements would bolster confidence in earnings sustainability.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▼ -66.2%

vs S&P -83.0pp

Revenue 3Y CAGR

▲ +28.0%

5Y: +28.8%

Net Margin

8.7%

▲ 3Y ago: 0.3%

ROIC

22.3%

▲ 3Y ago: 1.3%

FCF Margin

-6.4%

▼ 3Y ago: -5.2%

Piotroski

2/9

Weak

Vital Farms has delivered explosive top‑line growth, with revenue expanding 25.3% YoY to $759 M and a three‑year CAGR of 28%, yet the equity price has plummeted 66% over the past year, reflecting severe market dislocation rather than fundamentals. The company’s profitability metrics remain robust—ROE of 18.9% and ROIC of 22.3%—indicating that earnings are generated efficiently on a relatively small capital base (D/E = 0.15). Strong liquidity (current ratio 2.16) and an Altman Z‑score of 8.0 underscore a solid balance sheet, while cash conversion remains tight with a 41‑day cash conversion cycle. However, negative free‑cash‑flow margin (-6.35%) and modest operating cash flow coverage (OCF/NI = 0.51) highlight cash generation constraints that could pressure the firm if growth slows. The combination of high growth, attractive returns on capital, and a sound financial footing suggests upside potential if the market re‑prices the stock, but execution risk around cash conversion must be monitored.

✅ Strengths

Revenue is expanding at a 28% three‑year CAGR, driven by a 25.3% YoY increase to $759 M, which fuels earnings growth and supports the high ROIC of 22.3%.
ROE of 18.9% and ROIC of 22.3% far exceed the cost of capital implied by a beta of 1.07, indicating that Vital Farms creates value for shareholders despite recent price weakness.
The balance sheet is ultra‑conservative with a debt‑to‑equity ratio of only 0.15 and an interest coverage ratio of 101.1x, providing ample headroom to fund continued expansion without refinancing risk.

⚠️ Risks

Free cash flow margin is negative at -6.35% and operating cash flow covers just 51% of net income, raising the possibility of liquidity strain if revenue growth decelerates.
The stock’s volatility is high (57.7%) with a max drawdown of 84.2%, suggesting that investors could face large price swings while the market re‑evaluates the company’s fundamentals.
Piotroski score of only 2/9 points to weak accounting signals such as limited earnings quality and cash flow consistency, which may undermine confidence in the sustainability of current profit margins.

VITL

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-07-31 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.